169 related articles for article (PubMed ID: 37437526)
1. Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization.
Park S; Chang J; Hong SP; Jin ES; Kong MG; Choi HY; Kwon SS; Park GM; Park RW
J Cardiovasc Pharmacol; 2023 Oct; 82(4):318-326. PubMed ID: 37437526
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
[TBL] [Abstract][Full Text] [Related]
3. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
McClellan KJ; Plosker GL
Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
[TBL] [Abstract][Full Text] [Related]
5. Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
Kim YH; Her AY; Rha SW; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Am J Cardiovasc Drugs; 2018 Apr; 18(2):117-127. PubMed ID: 29143297
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of trimetazidine in non-ischemic heart failure patients: a meta-analysis of randomized controlled trials.
Zhao C; Jin C; He X; Xiang M
Rev Cardiovasc Med; 2021 Dec; 22(4):1451-1459. PubMed ID: 34957784
[TBL] [Abstract][Full Text] [Related]
7. Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
Danchin N
Am J Cardiol; 2006 Sep; 98(5A):8J-13J. PubMed ID: 16931200
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study.
Shen L; Qiu L; Liu J; Li N; Shu H; Zhou N
Adv Ther; 2022 Jan; 39(1):655-673. PubMed ID: 34846710
[TBL] [Abstract][Full Text] [Related]
10. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up.
Xu X; Zhang W; Zhou Y; Zhao Y; Liu Y; Shi D; Zhou Z; Ma H; Wang Z; Yu M; Ma Q; Gao F; Shen H; Zhang J
Clin Drug Investig; 2014 Apr; 34(4):251-8. PubMed ID: 24470342
[TBL] [Abstract][Full Text] [Related]
11. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine for stable angina.
Ciapponi A; Pizarro R; Harrison J
Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
[TBL] [Abstract][Full Text] [Related]
13. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
14. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Zhu K; Zheng YS; Fang Y
Medicine (Baltimore); 2020 Oct; 99(44):e22918. PubMed ID: 33126352
[TBL] [Abstract][Full Text] [Related]
15. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.
Kim JS; Kim CH; Chun KJ; Kim JH; Park YH; Kim J; Choi JH; Lee SH; Kim EJ; Yu DG; Ahn EY; Jeong MH
Clin Res Cardiol; 2013 Dec; 102(12):915-22. PubMed ID: 23982468
[TBL] [Abstract][Full Text] [Related]
16. The role of trimetazidine after acute myocardial infarction.
Banach M; Rysz J; Goch A; Mikhailidis DP; Rosano GM
Curr Vasc Pharmacol; 2008 Oct; 6(4):282-91. PubMed ID: 18855716
[TBL] [Abstract][Full Text] [Related]
17. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
18. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
[TBL] [Abstract][Full Text] [Related]
20. [The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Vasiuk IuA; Shal'nova SA; Shkol'nik EL; Kulikov KG
Kardiologiia; 2011; 51(6):11-5. PubMed ID: 21878064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
